Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 DKK | +3.09% | -4.57% | -20.10% |
Sales 2024 * | 40M 5.82M | Sales 2025 * | - | Capitalization | 634M 92.21M |
---|---|---|---|---|---|
Net income 2024 * | -38M -5.53M | Net income 2025 * | - | EV / Sales 2024 * | 15.9 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-16.7
x | P/E ratio 2025 * |
-
| Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.17% |
Latest transcript on BioPorto A/S
1 day | +3.09% | ||
1 week | -4.57% | ||
1 month | +28.86% | ||
3 months | +5.70% | ||
6 months | -21.04% | ||
Current year | -20.10% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 13-07-17 | |
Ursula Klause
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Prasad Devarajan
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John McDonough
CHM | Chairman | 65 | 21-04-28 |
Donnie Hardison
BRD | Director/Board Member | 74 | 21-04-28 |
Chief Executive Officer | 64 | 13-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.67 | +3.09% | 136,135 |
24-05-30 | 1.62 | +0.62% | 349,750 |
24-05-29 | 1.61 | -5.41% | 356,933 |
24-05-28 | 1.702 | -0.47% | 243,102 |
24-05-27 | 1.71 | -2.29% | 409,384 |
Delayed Quote Nasdaq Copenhagen, May 31, 2024 at 10:44 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.10% | 92.19M | |
-3.43% | 12.45B | |
-3.17% | 8.22B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- BIOPOR Stock